Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.
暂无分享,去创建一个
M. Netea | B. Kullberg | J. V. D. van der Meer | Ineke C Verschueren | F. L. van de Veerdonk | Jos W M van der Meer | Mihai G Netea | Ineke Verschueren | Bart Jan Kullberg | Frank van de Veerdonk
[1] B. Pulendran,et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. , 2006, The Journal of clinical investigation.
[2] S. Akira,et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.
[3] A. Aderem,et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Netea,et al. Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells , 2004, The Journal of Immunology.
[5] Claire Collins,et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. , 2006, The Journal of clinical investigation.
[6] M. Netea,et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. , 1996, The Journal of clinical investigation.
[7] J. O'connor,et al. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. , 2004, Microbes and infection.
[8] J. O'connor,et al. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida -induced production of cytokines. , 2004, European cytokine network.
[9] T. Klein,et al. Involvement of mannose receptor in cytokine interleukin-1beta (IL-1beta), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1beta (MIP-1beta), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages , 1997, Infection and immunity.
[10] R. Coffman,et al. Interleukin‐4 and ‐10 exacerbate candidiasis in mice , 1995, European journal of immunology.
[11] S. Akira,et al. Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.
[12] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[13] R. Lehrer,et al. Interaction of Candida albicans with Human Leukocytes and Serum , 1969, Journal of bacteriology.
[14] M. Netea,et al. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. , 1999, Journal of immunology.
[15] M. Netea,et al. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. , 2002, The Journal of infectious diseases.
[16] B. Kullberg,et al. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1 , 1990, Infection and immunity.
[17] R. Wenzel,et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] K. Triantafilou,et al. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. , 2002, Trends in immunology.
[19] Linda N. Lee,et al. Secretion of Proinflammatory Cytokines and Chemokines during Amphotericin B Exposure Is Mediated by Coactivation of Toll-Like Receptors 1 and 2 , 2005, Antimicrobial Agents and Chemotherapy.
[20] S. Gordon,et al. Characteristics of Invasive Candidiasis in Gamma Interferon- and Interleukin-4-Deficient Mice: Role of Macrophages in Host Defense against Candida albicans , 1998, Infection and Immunity.
[21] T. Hartung,et al. Membrane Sorting of Toll-like Receptor (TLR)-2/6 and TLR2/1 Heterodimers at the Cell Surface Determines Heterotypic Associations with CD36 and Intracellular Targeting* , 2006, Journal of Biological Chemistry.
[22] Shizuo Akira,et al. Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2 , 2003, The Journal of experimental medicine.
[23] S. Gordon,et al. Dectin-1 is required for β-glucan recognition and control of fungal infection , 2007, Nature Immunology.
[24] S. Melnick,et al. Mechanism of macrophage activation by (1,4)-α-d-glucan isolated from Tinospora cordifolia , 2006 .
[25] Siamon Gordon,et al. Dectin-1 Is A Major β-Glucan Receptor On Macrophages , 2002, The Journal of experimental medicine.
[26] B. Kullberg,et al. Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. , 1993, The Journal of infectious diseases.
[27] Shane Gillespie,et al. Attributable mortality of nosocomial candidemia, revisited. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] M. Chamaillard,et al. Specific Recognition of Candida albicans by Macrophages Requires Galectin-3 to Discriminate Saccharomyces cerevisiae and Needs Association with TLR2 for Signaling1 , 2006, The Journal of Immunology.
[29] A. Mantovani,et al. The Contribution of the Toll-Like/IL-1 Receptor Superfamily to Innate and Adaptive Immunity to Fungal Pathogens In Vivo1 , 2004, The Journal of Immunology.
[30] Osamu Takeuchi,et al. Candida albicans phospholipomannan is sensed through toll-like receptors. , 2003, The Journal of infectious diseases.
[31] E. Nemoto,et al. Saccharomyces cerevisiae‐ and Candida albicans‐Derived Mannan Induced Production of Tumor Necrosis Factor Alpha by Human Monocytes in a CD14‐ and Toll‐Like Receptor 4‐Dependent Manner , 2002, Microbiology and immunology.
[32] C. Hughes,et al. Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.
[33] J. Satagopan,et al. TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation , 2005, Annals of the New York Academy of Sciences.